Migraine Drugs Market 2020-2030 Global Industry Analysis
Migraine Drugs Market
is valued around USD 2014.1 Billion in 2019 and expected to reach USD 2971.9 Billion
by 2030 with the CAGR of 3.6% over the forecast period.
Migraine Drugs are used for the treatment of neurological condition
called as migraine. This condition involves the high intensity headache which
can last from hours up to days with several other symptoms such as vomiting,
nausea, sensitivity towards light, smell & other. There has been study
which proves that female population is more prone to migraine as compared to
the males. Migraine is highly manageable disorder with the help of proper
medication & slight change in the lifestyle.
Global Migraine
Drugs Market report is segmented on the basis of type, administration
route, distribution channel and by regional. Based upon type, the migraine
drugs market is fragmented into abortive medicine and preventive medicine. On
the basis of administration route, the market is categorized into oral,
injection and others. Based on distribution channel, the market is fragmented
into hospital-based pharmacies, retail pharmacies, and online pharmacies. The
regional bifurcation of countries includes North America, Europe, Asia-Pacific,
and RoW which are further segmented into major countries such as U.S., UK,
France, and others.
The migraine drugs market is mainly driven by the high prevalence rate
of migraine along with growing awareness among people which in turn created the
demand for migraine drugs. There has been technological advancement with robust
product pipeline along with constant product launch. In addition, growing healthcare
expenditure as well as FDA approvals to novel therapies for the better management
of migraine is also expected to contribute market growth. On the other hand,
constant growth in female population accompanied by rising awareness with
respect to treatment & prevention of migraine followed by the various
organizations aim to further create awareness among large population has
anticipated the market growth. However, various side effects associated with
the migraine drugs restrain the market growth in near future.
Download sample copy of this report at https://www.nextmsc.com/Migraine-Drugs-Market/request-sample
The developed regions such as North America and Europe are expected to
hold the major market share owing to the presence of major market players in
the region followed by technological advancement with rapid use of novel
therapies. Asia Pacific is expected to dominate the migraine drugs market in
terms of growth rate owing to the high prevalence rate along with huge female
population. Moreover, rising healthcare expenditure along with growing
awareness among people with regards to the treatment & prevention of
migraine are also expected to support the market growth over the forecast
period.
The major market players profiled in the migraine drugs market includes Allergan
Plc., AstraZeneca, GlaxoSmithKline Plc., Impax Laboratories, Abbott
Laboratories, Eisai Co., Ltd., Johnson & Johnson, Merck & Co., Endo
International Plc, and Pfizer Inc. among others.
About Us:
Next Move Strategy Consulting is an independent and trusted
third-platform market intelligence provider, committed to deliver high quality,
market research reports that help multinational companies to triumph over their
competitions and increase industry footprint by capturing greater market share.
Our research model is a unique collaboration of primary research, secondary
research, data mining and data analytics.
We have been servicing over 1000 customers globally that includes 90% of
the Fortune 500 companies over a decade. Our analysts are constantly tracking
various high growth markets and identifying hidden opportunities in each sector
or the industry. We provide one of the industry’s best quality syndicate as
well as custom research reports across 10 different industry verticals. We are
committed to deliver high quality research solutions in accordance to your
business needs. Our industry standard delivery solutions that ranges from the
pre consultation to after-sales services, provide an excellent client
experience and ensure right strategic decision making for businesses.
Contact
US:
Joseph
Lawrence (Head - Client Engagement & Servicing)
Joseph@nextmsc.com
Comments
Post a Comment